Pierre Fustier

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

John P. Leonard, Marek Trněný, Koji Izutsu et al. · Journal of Clinical Oncology · 2019 · 401 citations · Full text

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Myron S. Czuczman, Marek Trněný, Andrew Davies et al. · Clinical Cancer Research · 2017 · 164 citations · Full text

High Glucose Stimulates Angiotensinogen Gene Expression and Cell Hypertrophy via Activation of the Hexosamine Biosynthesis Pathway in Rat Kidney Proximal Tubular Cells

Tusty‐Jiuan Hsieh, Pierre Fustier, Shao‐Ling Zhang et al. · Endocrinology · 2003 · 94 citations · Full text

P38 Mapk, Cellular Physiology, Oxidative Stress +18

Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines

Pierre Fustier, Ludovic Le Corre, Nasséra Chalabi et al. · British Journal of Cancer · 2003 · 51 citations · Full text

Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines

Ludovic Le Corre, Pierre Fustier, Nasséra Chalabi et al. · Clinica Chimica Acta · 2004 · 51 citations

Reductive Stress, Breast Oncology, Medicine +6